Memorial Sloan Kettering Cancer Center (Site 210) — New York, New York

Memorial Sloan Kettering Cancer Center (Site 210) is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Memorial Sloan Kettering Cancer Center (Site 210) has participated in 1 clinical trials.

Therapeutic areas: Neurofibromatosis 2, Progressive Vestibular Schwannoma (VS).

Sponsors: University of Alabama at Birmingham.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Memorial Sloan Kettering Cancer Center (Site 210)?

Memorial Sloan Kettering Cancer Center (Site 210) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Memorial Sloan Kettering Cancer Center (Site 210) conducted?

Memorial Sloan Kettering Cancer Center (Site 210) has 1 clinical trials on record. Their work covers Neurofibromatosis 2, Progressive Vestibular Schwannoma (VS).

Is Memorial Sloan Kettering Cancer Center (Site 210) accredited by Crixeo Health?

Memorial Sloan Kettering Cancer Center (Site 210) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Memorial Sloan Kettering Cancer Center (Site 210)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.